NO20031648L - Farmasöytiske lösninger av modafinilforbindelser - Google Patents
Farmasöytiske lösninger av modafinilforbindelserInfo
- Publication number
- NO20031648L NO20031648L NO20031648A NO20031648A NO20031648L NO 20031648 L NO20031648 L NO 20031648L NO 20031648 A NO20031648 A NO 20031648A NO 20031648 A NO20031648 A NO 20031648A NO 20031648 L NO20031648 L NO 20031648L
- Authority
- NO
- Norway
- Prior art keywords
- modafinil compounds
- pharmaceutical solutions
- modafinil
- pharmaceutical
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23948800P | 2000-10-11 | 2000-10-11 | |
US09/974,473 US6489363B2 (en) | 2000-10-11 | 2001-10-10 | Pharmaceutical solutions of modafinil compounds |
PCT/US2001/031685 WO2002030413A1 (en) | 2000-10-11 | 2001-10-11 | Pharmaceutical solutions of modafinil compounds |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20031648D0 NO20031648D0 (no) | 2003-04-10 |
NO20031648L true NO20031648L (no) | 2003-06-04 |
NO333096B1 NO333096B1 (no) | 2013-03-04 |
Family
ID=26932612
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20031648A NO333096B1 (no) | 2000-10-11 | 2003-04-10 | Farmasoytisk preparat og anvendelse derav |
Country Status (22)
Country | Link |
---|---|
US (1) | US6489363B2 (no) |
EP (1) | EP1324755B1 (no) |
JP (1) | JP2004510816A (no) |
KR (1) | KR100846914B1 (no) |
CN (1) | CN100518726C (no) |
AT (1) | ATE478662T1 (no) |
AU (2) | AU2001296785B2 (no) |
BG (1) | BG66221B1 (no) |
BR (1) | BR0114813A (no) |
CA (1) | CA2425218C (no) |
CZ (1) | CZ2003966A3 (no) |
DE (1) | DE60142913D1 (no) |
EA (1) | EA005572B1 (no) |
HK (1) | HK1057336A1 (no) |
HU (1) | HU229424B1 (no) |
IL (2) | IL155263A0 (no) |
MX (1) | MXPA03003150A (no) |
NO (1) | NO333096B1 (no) |
NZ (1) | NZ525166A (no) |
PL (1) | PL214879B1 (no) |
SK (1) | SK287436B6 (no) |
WO (1) | WO2002030413A1 (no) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU229409B1 (en) * | 2000-10-11 | 2013-12-30 | Cephalon | Compositions comprising modafinil compounds |
US6919378B2 (en) * | 2000-10-11 | 2005-07-19 | Cephalon, Inc. | Pharmaceutical solutions of modafinil compounds |
US6992219B2 (en) * | 2002-08-09 | 2006-01-31 | Cephalon France | Modafinil polymorphic forms |
US20040116532A1 (en) * | 2002-09-13 | 2004-06-17 | Craig Heacock | Pharmaceutical formulations of modafinil |
FR2849029B1 (fr) * | 2002-12-20 | 2005-03-18 | Lafon Labor | Procede de preparation et formes cristallines des enantiomeres optiques du modafinil. |
DK1610796T3 (da) * | 2003-03-17 | 2014-07-21 | Neurohealing Pharmaceuticals Inc | Højpotent dopaminerg behandling af neurologisk svækkelse, som er forbundet med hjerneskade |
US20040253308A1 (en) * | 2003-04-29 | 2004-12-16 | Barr Laboratories, Inc. | Surface-treated modafinil particles |
US8153159B2 (en) * | 2003-09-18 | 2012-04-10 | Cephalon, Inc. | Modafinil modified release pharmaceutical compositions |
US7368591B2 (en) | 2003-09-19 | 2008-05-06 | Cephalon France | Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation |
US20060024370A1 (en) * | 2004-07-29 | 2006-02-02 | Cephalon France | Modafinil oral lyophilizate |
BRPI0500520A (pt) * | 2005-02-16 | 2006-09-26 | Henry Jun Suzuki | uso de agentes flavorizantes aromáticos de alto ponto de fusão como agentes solubilizantes ou inibidores de cristalização em composições farmacêuticas |
WO2007013962A2 (en) * | 2005-07-21 | 2007-02-01 | Neurohealing Pharmaceuticals, Inc. | Rapid onset and short term modafinil compositions and methods of use thereof |
DK2056811T3 (en) * | 2006-08-14 | 2018-05-22 | Neurohealing Pharmaceuticals Inc | Modafinil-based treatment for premature ejaculation |
US8173169B2 (en) * | 2007-07-11 | 2012-05-08 | Hikma Pharmaceuticals | Formulation and process for the preparation of modafinil |
CA2629979A1 (en) * | 2008-04-25 | 2009-10-25 | Pharmascience Inc. | Novel resveratrol compositions |
FR2987265B1 (fr) | 2012-02-28 | 2014-02-28 | Debregeas Et Associes Pharma | Composition pharmaceutique sous forme de sirop a base de modafinil, son procede de fabrication et son application |
FR2987266B1 (fr) | 2012-02-28 | 2014-12-19 | Debregeas Et Associes Pharma | Procede d'obtention d'une composition pharmaceutique a base de modafinil, composition pharmaceutique ainsi obtenue et son application |
SG11201503051QA (en) * | 2012-10-18 | 2015-05-28 | Abbvie Inc | Formulations of pyrimidinedione derivative compounds |
US9616068B2 (en) | 2014-10-27 | 2017-04-11 | Pohela LLC | Animal training using cognitive enhancement |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1584462A (en) | 1977-03-31 | 1981-02-11 | Lafon Labor | N-diaryl-malonamide and diarylmethyl-sulphinyl-acetamide derivatives and pharmaceutical compositions containing them |
FR2593809B1 (fr) * | 1986-01-31 | 1988-07-22 | Lafon Labor | Benzhydrylsulfinylacetamide, procede de preparation et utilisation en therapeutique |
FR2663225B1 (fr) | 1990-06-14 | 1994-11-04 | Lafon Labor | Nouvelle utilisation du modafinil. |
US5618845A (en) * | 1994-10-06 | 1997-04-08 | Cephalon, Inc. | Acetamide derivative having defined particle size |
FR2771004B1 (fr) | 1997-11-19 | 2000-02-18 | Inst Curie | Utilisation de derives de benzhydryl sulfinyle pour la fabrication de medicaments ayant un effet eveillant dans des situations de troubles de la vigilance d'origine medicamenteuse |
US6200968B1 (en) | 1998-08-06 | 2001-03-13 | Cephalon, Inc. | Particle-forming compositions containing fused pyrrolocarbazoles |
US20010034373A1 (en) | 2000-02-09 | 2001-10-25 | Matthew Miller | Low dose modafinil for enhancement of cognitive function |
-
2001
- 2001-10-10 US US09/974,473 patent/US6489363B2/en not_active Expired - Lifetime
- 2001-10-11 EA EA200300450A patent/EA005572B1/ru not_active IP Right Cessation
- 2001-10-11 WO PCT/US2001/031685 patent/WO2002030413A1/en active Application Filing
- 2001-10-11 MX MXPA03003150A patent/MXPA03003150A/es active IP Right Grant
- 2001-10-11 PL PL361134A patent/PL214879B1/pl unknown
- 2001-10-11 DE DE60142913T patent/DE60142913D1/de not_active Expired - Lifetime
- 2001-10-11 AU AU2001296785A patent/AU2001296785B2/en not_active Ceased
- 2001-10-11 AU AU9678501A patent/AU9678501A/xx active Pending
- 2001-10-11 CA CA2425218A patent/CA2425218C/en not_active Expired - Fee Related
- 2001-10-11 HU HU0302478A patent/HU229424B1/hu not_active IP Right Cessation
- 2001-10-11 AT AT01977685T patent/ATE478662T1/de not_active IP Right Cessation
- 2001-10-11 CN CNB018171273A patent/CN100518726C/zh not_active Expired - Fee Related
- 2001-10-11 NZ NZ525166A patent/NZ525166A/en not_active IP Right Cessation
- 2001-10-11 SK SK440-2003A patent/SK287436B6/sk not_active IP Right Cessation
- 2001-10-11 JP JP2002533856A patent/JP2004510816A/ja active Pending
- 2001-10-11 CZ CZ2003966A patent/CZ2003966A3/cs unknown
- 2001-10-11 KR KR1020037005057A patent/KR100846914B1/ko not_active IP Right Cessation
- 2001-10-11 IL IL15526301A patent/IL155263A0/xx active IP Right Review Request
- 2001-10-11 EP EP01977685A patent/EP1324755B1/en not_active Expired - Lifetime
- 2001-10-11 BR BR0114813-3A patent/BR0114813A/pt active Search and Examination
-
2003
- 2003-04-06 IL IL155263A patent/IL155263A/en not_active IP Right Cessation
- 2003-04-10 NO NO20031648A patent/NO333096B1/no not_active IP Right Cessation
- 2003-04-14 BG BG107720A patent/BG66221B1/bg unknown
-
2004
- 2004-01-09 HK HK04100157.5A patent/HK1057336A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20031648L (no) | Farmasöytiske lösninger av modafinilforbindelser | |
HK1079446A1 (en) | Pharmeceutical solid dispersions of modafinil compounds | |
LTC1620113I2 (lt) | Ivermektino topinė kompozicija, skirta dermatologinių susirgimų gydymui | |
ATE491436T1 (de) | Zusammensetzungen gegen infektionen zur behandlung erkrankten gewebes wie z.b. fieberbläschen | |
SE0100901D0 (sv) | New composition | |
ATE478840T1 (de) | 3-aminoazetidinderivate enthaltende pharmazeutische zusammensetzungen, diese derivate und deren herstellung | |
ATE512163T1 (de) | Verabreichung von mitteln zur behandlung von entzündungen | |
DE60313597D1 (de) | Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis | |
DE60235083D1 (de) | Substituierte tetracyclin-verbindungen zur behandlung von malaria | |
PT1313489E (pt) | Composicoes farmaceuticas para o tratamento de mucosite, estomatite e sindroma de behcet | |
DE502004002571D1 (de) | Substituierte 3-pyrrolidin-indol-derivate | |
BR0318278A (pt) | compostos de éter aminocicloexìlico e usos dos mesmo | |
CY1110061T1 (el) | Συνθεσεις περιλαμβανοντας ενωσεις μοδαφινιλης | |
PE20030061A1 (es) | 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4 | |
WO2003066597A3 (en) | Guanidino compounds | |
NO20040726L (no) | Kombinasjonspreparater av arylsubstituerte propanolaminderivater med andre aktive forbindelser og anvendelse derav. | |
EE200300064A (et) | Farmatseutiline kompositsioon C. pneumoniae pooltpõhjustatud infektsioonide raviks ja/või ennetamiseks, mahekompositsioon ja nende kasutamine | |
NO20051261L (no) | Morfin-6-glukuronidsalt | |
EA200300727A1 (ru) | Производные 2h-1-бензопирана, способы их получения и их фармацевтические композиции | |
SE0001916D0 (sv) | Novel formulation | |
ATE241640T1 (de) | Fusidinsäure-derivate | |
SE0300535D0 (sv) | Treatment of burns | |
ATE465989T1 (de) | 13-substituierte methacyclinverbindungen | |
ATE382363T1 (de) | Pharmazeutische zusammensetzung enthaltend bulbophyllum | |
WO2000050023A3 (en) | Use of tamoxifen and related compounds as CLC3 blockers in the treatment of vascular diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |